Bacillus Clausii Septicemia in a Pediatric Patient After Treatment With Probiotics

Area of Science:

• Microbiology
• Pediatric Medicine
• Infectious Diseases

Background:

• Probiotics are widely used for gastrointestinal health.
• Isolated instances of probiotic-associated septicemia have been documented.
• Bacillus clausii is a common probiotic spore-forming bacterium.

Observation:

• A 4-month-old infant with congenital heart disease received a probiotic containing B. clausii spores for diarrhea.
• The infant developed Bacillus clausii septicemia.
• The infection was refractory to antibiotic treatment.

Findings:

• The B. clausii septicemia progressed to a multidrug-resistant sepsis.
• Multiorgan failure occurred in the infant.
• This case highlights a severe adverse event associated with B. clausii probiotics.

Implications:

• Clinicians should be aware of the potential risks of probiotic use, especially in immunocompromised or critically ill infants.
• Further research is needed to understand the mechanisms and risk factors for probiotic-associated infections.
• This case underscores the importance of careful patient selection and monitoring when administering probiotics to vulnerable populations.